{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:45:51Z","timestamp":1767181551670,"version":"build-2238731810"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1001757"],"award-info":[{"award-number":["G1001757"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N023668\/1"],"award-info":[{"award-number":["MR\/N023668\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 Al100657"],"award-info":[{"award-number":["P01 Al100657"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CHAVI-ID, subcontract 210782"],"award-info":[{"award-number":["CHAVI-ID, subcontract 210782"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272016C"],"award-info":[{"award-number":["HHSN272016C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010686","name":"H2020 European Institute of Innovation and Technology","doi-asserted-by":"publisher","award":["681137"],"award-info":[{"award-number":["681137"]}],"id":[{"id":"10.13039\/100010686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181886","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T13:26:18Z","timestamp":1502285178000},"page":"e0181886","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers"],"prefix":"10.1371","volume":"12","author":[{"given":"Silvia","family":"Capucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund G.","family":"Wee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torben","family":"Schiffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia C.","family":"LaBranche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Borthwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Cupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansi","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quentin","family":"Sattentau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per J.","family":"Klasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogier W.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-9546","authenticated-orcid":true,"given":"Tom\u00e1\u0161","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"issue":"6091","key":"ref1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.1225416","article-title":"Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses","volume":"337","author":"DR Burton","year":"2012","journal-title":"Science"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/imr.12005","article-title":"Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA","volume":"250","author":"JP Julien","year":"2012","journal-title":"Immunological reviews"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/14712598.2014.885946","article-title":"Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines","volume":"14","author":"T Hanke","year":"2014","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.chom.2016.02.002","article-title":"HIV-Host Interactions: Implications for Vaccine Design","volume":"19","author":"BF Haynes","year":"2016","journal-title":"Cell host & microbe"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2014.04.008","article-title":"Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers","volume":"40","author":"C Blattner","year":"2014","journal-title":"Immunity"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","article-title":"Broadly neutralizing antiviral antibodies","volume":"31","author":"D Corti","year":"2013","journal-title":"Annual review of immunology"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"E Falkowska","year":"2014","journal-title":"Immunity"},{"key":"ref8","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface","author":"J Huang","year":"2014","journal-title":"Nature"},{"issue":"7424","key":"ref9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"J Huang","year":"2012","journal-title":"Nature"},{"key":"ref10","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","author":"F Klein","year":"2012","journal-title":"Nature"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"e24078","DOI":"10.1371\/journal.pone.0024078","article-title":"Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses","volume":"6","author":"H Mouquet","year":"2011","journal-title":"PloS one"},{"issue":"6049","key":"ref12","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"JF Scheid","year":"2011","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"16199","DOI":"10.1038\/nmicrobiol.2016.199","article-title":"An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability","volume":"2","author":"MJ van Gils","year":"2016","journal-title":"Nat Microbiol"},{"issue":"7365","key":"ref14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"LM Walker","year":"2011","journal-title":"Nature"},{"issue":"5950","key":"ref15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"LM Walker","year":"2009","journal-title":"Science"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2014.01.052","article-title":"Structural insights on the role of antibodies in HIV-1 vaccine and therapy","volume":"156","author":"AP West Jr.","year":"2014","journal-title":"Cell"},{"issue":"6049","key":"ref17","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"X Wu","year":"2011","journal-title":"Science"},{"issue":"5993","key":"ref18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"T Zhou","year":"2010","journal-title":"Science"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","article-title":"Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies","volume":"39","author":"T Zhou","year":"2013","journal-title":"Immunity"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"e1002721","DOI":"10.1371\/journal.ppat.1002721","article-title":"Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape","volume":"8","author":"KJ Bar","year":"2012","journal-title":"PLoS pathogens"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1086\/651144","article-title":"Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression","volume":"201","author":"Z Euler","year":"2010","journal-title":"J Infect Dis"},{"issue":"19","key":"ref22","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1128\/JVI.01149-09","article-title":"Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression","volume":"83","author":"A Piantadosi","year":"2009","journal-title":"Journal of virology"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm1297-1389","article-title":"Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1","volume":"3","author":"MC Gauduin","year":"1997","journal-title":"Nature medicine"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"e1000433","DOI":"10.1371\/journal.ppat.1000433","article-title":"Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers","volume":"5","author":"AJ Hessell","year":"2009","journal-title":"PLoS pathogens"},{"issue":"16","key":"ref25","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1128\/JVI.75.16.7470-7480.2001","article-title":"Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge","volume":"75","author":"R Hofmann-Lehmann","year":"2001","journal-title":"Journal of virology"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/72318","article-title":"Protection of macaques against vaginal transmission of a pathogenic HIV-1\/SIV chimeric virus by passive infusion of neutralizing antibodies","volume":"6","author":"JR Mascola","year":"2000","journal-title":"Nature medicine"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1568005054201580","article-title":"Antibodies: can they protect against HIV infection?","volume":"5","author":"CM Mc Cann","year":"2005","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"46","key":"ref28","doi-asserted-by":"crossref","first-page":"18921","DOI":"10.1073\/pnas.1214785109","article-title":"Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo","volume":"109","author":"B Moldt","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1084\/jem.20132494","article-title":"Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques","volume":"211","author":"M Shingai","year":"2014","journal-title":"The Journal of experimental medicine"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nm833","article-title":"Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120","volume":"9","author":"RS Veazey","year":"2003","journal-title":"Nature medicine"},{"issue":"7446","key":"ref31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"HX Liao","year":"2013","journal-title":"Nature"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nm.2689","article-title":"HIV-1 Env antibodies: are we in a bind or going blind?","volume":"18","author":"JP Moore","year":"2012","journal-title":"Nature medicine"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"e1003618","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"RW Sanders","year":"2013","journal-title":"PLoS pathogens"},{"key":"ref34","article-title":"Crystal Structure of a Soluble Cleaved HIV-1","author":"JP Julien","year":"2013","journal-title":"Envelope Trimer. Science"},{"issue":"6165","key":"ref35","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.1245627","article-title":"Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer","volume":"342","author":"D Lyumkis","year":"2013","journal-title":"Science"},{"issue":"45","key":"ref36","doi-asserted-by":"crossref","first-page":"18256","DOI":"10.1073\/pnas.1314351110","article-title":"Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation","volume":"110","author":"RP Ringe","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.cell.2015.11.056","article-title":"Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes","volume":"163","author":"SW de Taeye","year":"2015","journal-title":"Cell"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"e1005864","DOI":"10.1371\/journal.ppat.1005864","article-title":"Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C","volume":"12","author":"PJ Klasse","year":"2016","journal-title":"PLoS pathogens"},{"issue":"6244","key":"ref39","doi-asserted-by":"crossref","first-page":"aac4223","DOI":"10.1126\/science.aac4223","article-title":"HIV-1 neutralizing antibodies induced by native-like envelope trimers","volume":"349","author":"RW Sanders","year":"2015","journal-title":"Science"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/imr.12481","article-title":"Native-like Env trimers as a platform for HIV-1 vaccine design","volume":"275","author":"RW Sanders","year":"2017","journal-title":"Immunological reviews"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"e107903","DOI":"10.1371\/journal.pone.0107903","article-title":"Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure","volume":"9","author":"S Biswas","year":"2014","journal-title":"PloS one"},{"issue":"44","key":"ref42","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1016\/j.vaccine.2010.08.068","article-title":"Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1","volume":"28","author":"AD Douglas","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.4049\/jimmunol.1001760","article-title":"Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines","volume":"185","author":"SJ Draper","year":"2012","journal-title":"Journal of immunology"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/imm.12226","article-title":"Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection","volume":"141","author":"SC Elias","year":"2014","journal-title":"Immunology"},{"issue":"17","key":"ref45","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1411627","article-title":"A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA","volume":"374","author":"K Ewer","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/mt.2012.223","article-title":"ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans","volume":"20","author":"SH Sheehy","year":"2013","journal-title":"Mol Ther"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"N Borthwick","year":"2014","journal-title":"Mol Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8(+) T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation","volume":"4","author":"KJ Ewer","year":"2013","journal-title":"Nat Commun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/mtm.2016.61","article-title":"Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults","volume":"3","author":"G Mutua","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jiw244","article-title":"Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S\/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP","volume":"214","author":"T Rampling","year":"2016","journal-title":"J Infect Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"MDJ Dicks","year":"2012","journal-title":"PloS one"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/mt.2016.3","article-title":"Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection","volume":"24","author":"B Ondondo","year":"2016","journal-title":"Mol Ther"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1073\/pnas.1217537110","article-title":"Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9","volume":"110","author":"JP Julien","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref54","article-title":"Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1","author":"M Sarzotti-Kelsoe","year":"2013","journal-title":"J Immunol Methods"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/JVI.02853-13","article-title":"Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"88","author":"A deCamp","year":"2014","journal-title":"Journal of virology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/mt.2015.210","article-title":"Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition","volume":"24","author":"S Abdul-Jawad","year":"2016","journal-title":"Mol Ther"},{"key":"ref57","article-title":"Dual aggregation-induced emission for enhanced fluorescence sensing of furin activity in vitro and in living cells","author":"X Liu","year":"2016","journal-title":"Chem Commun (Camb)"},{"issue":"17","key":"ref58","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1097\/QAD.0000000000000468","article-title":"Optimizing parallel induction of HIV type 1-specific antibody and T-cell responses by multicomponent subunit vaccines","volume":"28","author":"G Clutton","year":"2014","journal-title":"Aids"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ni.3158","article-title":"Antibody responses to envelope glycoproteins in HIV-1 infection","volume":"16","author":"DR Burton","year":"2015","journal-title":"Nat Immunol"},{"issue":"3","key":"ref60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.it.2016.01.007","article-title":"HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies","volume":"37","author":"SW de Taeye","year":"2016","journal-title":"Trends Immunol"},{"issue":"6244","key":"ref61","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.aac5894","article-title":"Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen","volume":"349","author":"JG Jardine","year":"2015","journal-title":"Science"},{"issue":"6215","key":"ref62","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1259206","article-title":"Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies","volume":"346","author":"AT McGuire","year":"2014","journal-title":"Science"},{"issue":"7","key":"ref63","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.cell.2015.06.003","article-title":"Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice","volume":"161","author":"P Dosenovic","year":"2015","journal-title":"Cell"},{"issue":"5","key":"ref64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nbt.2197","article-title":"B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study","volume":"30","author":"BF Haynes","year":"2012","journal-title":"Nat Biotechnol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.virol.2015.08.002","article-title":"Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers","volume":"486","author":"K Sliepen","year":"2015","journal-title":"Virology"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0293148","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T01:33:49Z","timestamp":1569980029000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181886"}},"subtitle":[],"editor":[{"given":"Shibo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":65,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181886","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]}}}